Skip to content

Updated ICER Patient Input Guide


The voice of migraine patients must be heard!
ICER is evaluating the new CGRP inhibitor medicines and they have refused our request to have a migraine patient or a headache specialist on the voting panel. They must hear from patients via written submissions so that the voting panel understands the pain, disability and burden of migraine disease and the desperate need for access to more effective treatments.

Submit your personal migraine story. Learn more by reading the Updated Patient Guide to ICER from the Headache and Migraine Policy Forum and patient advocate, Katie M. Golden of Golden Graine.

Scroll To Top